Early onset of effect following galcanezumab treatment in patients with previous preventive medication failures

BACKGROUND: Galcanezumab is a monoclonal antibody (mAb) that binds calcitonin gene-related peptide (CGRP) and is indicated for the preventive treatment of migraine. Galcanezumab demonstrated early onset of effect in patients with migraine but it is unknown whether the same holds true for patients wh...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Headache Pain
Main Authors: Schwedt, Todd J., Kuruppu, Dulanji K., Dong, Yan, Standley, Katherine, Yunes-Medina, Laura, Pearlman, Eric
Format: Artigo
Sprog:Inglês
Udgivet: Springer Milan 2021
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7992932/
https://ncbi.nlm.nih.gov/pubmed/33765912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-021-01230-w
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker